Fed. Circ. Says Teva Can't Block Cenestin Generic
By Leigh Kamping-Carder · July 21, 2011, 5:05 PM EDT
The Federal Circuit on Thursday ruled that Teva Women's Health Inc.'s decision to narrow the claims of a patent for the menopause drug Cenestin doomed its attempt to block Paddock Laboratories...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login